Business Description
Eris Lifesciences Ltd
ISIN : INE406M01024
Description
Financial Strength
5/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.5 | |||||
Equity-to-Asset | 0.37 | |||||
Debt-to-Equity | 1.08 | |||||
Debt-to-EBITDA | 3.98 | |||||
Interest Coverage | 5.8 | |||||
Piotroski F-Score | 5/9 | |||||
Altman Z-Score | 2.37 | |||||
Beneish M-Score | -2.26 | |||||
WACC vs ROIC |
Growth Rank
10/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 18.6 | |||||
3-Year EBITDA Growth Rate | 16.7 | |||||
3-Year EPS without NRI Growth Rate | 3.7 | |||||
3-Year FCF Growth Rate | 0.6 | |||||
3-Year Book Growth Rate | 17.9 | |||||
Future 3-5Y Total Revenue Growth Rate | 21.01 |
Momentum Rank
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 39.6 | |||||
9-Day RSI | 46.74 | |||||
14-Day RSI | 49.31 | |||||
6-1 Month Momentum % | -6.07 | |||||
12-1 Month Momentum % | 40.29 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 0.91 | |||||
Quick Ratio | 0.83 | |||||
Cash Ratio | 0.55 | |||||
Days Inventory | 147.12 | |||||
Days Sales Outstanding | 65.04 | |||||
Days Payable | 174.04 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -0.1 | |||||
Shareholder Yield % | -10.27 |
Profitability Rank
10/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 80.92 | |||||
Operating Margin % | 24.72 | |||||
Net Margin % | 19.69 | |||||
FCF Margin % | 17.92 | |||||
ROE % | 16.35 | |||||
ROA % | 8.06 | |||||
ROIC % | 9.76 | |||||
ROC (Joel Greenblatt) % | 58.24 | |||||
ROCE % | 13.92 | |||||
Years of Profitability over Past 10-Year | 10 |
GF Value Rank
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 30.46 | |||||
Forward PE Ratio | 20.75 | |||||
PE Ratio without NRI | 30.46 | |||||
Shiller PE Ratio | 34.58 | |||||
Price-to-Owner-Earnings | 46 | |||||
PEG Ratio | 2.27 | |||||
PS Ratio | 6 | |||||
PB Ratio | 4.61 | |||||
Price-to-Free-Cash-Flow | 33.46 | |||||
Price-to-Operating-Cash-Flow | 24.57 | |||||
EV-to-EBIT | 25.83 | |||||
EV-to-Forward-EBIT | 16.73 | |||||
EV-to-EBITDA | 19.08 | |||||
EV-to-Forward-EBITDA | 15.31 | |||||
EV-to-Revenue | 6.7 | |||||
EV-to-Forward-Revenue | 5.37 | |||||
EV-to-FCF | 37.59 | |||||
Price-to-Projected-FCF | 2.96 | |||||
Price-to-DCF (Earnings Based) | 1.36 | |||||
Price-to-DCF (FCF Based) | 3.61 | |||||
Price-to-Peter-Lynch-Fair-Value | 2.34 | |||||
Earnings Yield (Greenblatt) % | 3.87 | |||||
FCF Yield % | 2.99 | |||||
Forward Rate of Return (Yacktman) % | 14.35 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Eris Lifesciences Ltd Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil ₹) | 19,912.95 | ||
EPS (TTM) (₹) | 28.79 | ||
Beta | 0.54 | ||
Volatility % | 20.21 | ||
14-Day RSI | 49.31 | ||
14-Day ATR (₹) | 25.55446 | ||
20-Day SMA (₹) | 880.655 | ||
12-1 Month Momentum % | 40.29 | ||
52-Week Range (₹) | 617.5 - 971.9 | ||
Shares Outstanding (Mil) | 136.05 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 5 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Eris Lifesciences Ltd Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Eris Lifesciences Ltd Stock Events
Event | Date | Price(₹) | ||
---|---|---|---|---|
No Event Data |
Eris Lifesciences Ltd Frequently Asked Questions
What is Eris Lifesciences Ltd(NSE:ERIS)'s stock price today?
When is next earnings date of Eris Lifesciences Ltd(NSE:ERIS)?
Does Eris Lifesciences Ltd(NSE:ERIS) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |